Type 2 diabetes: New obesity drug may halve risk, aid weight loss – Medical News Today
Semaglutide is a polypeptide that physicians prescribe for the treatment of type 2 diabetes. The FDA has approved the use of Novo Nordisk’s Ozempic and Rybelsus as a once-weekly injection…